Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS by Pavelek, Zbyšek, Sobíšek, Lukáš, Šarláková, Jana, Potužník, Pavel, Peterka, Marek, Štětkárová, Ivana, Štourač, Pavel, Mareš, Jan, Hradílek, Pavel, Ampapa, Radek, Grünermelová, Markéta, Vachová, Marta, Recmanová, Eva, Angelucci, Francesco, Halúsková, Simona, Vališ, Martin

Get full text

Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry by Potuznik, Pavel, Drahota, Jiri, Horakova, Dana, Peterka, Marek, Mazouchova, Aneta, Matyas, David, Pavelek, Zbysek, Vachova, Marta, Recmanova, Eva, Stetkarova, Ivana, Libertinova, Jana, Mares, Jan, Stourac, Pavel, Grunermelova, Marketa, Martinkova, Alena, Adamkova, Jana, Hradilek, Pavel, Ampapa, Radek, Dufek, Michal, Kubala Havrdova, Eva, Stastna, Dominika

Get full text

Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia by Stastna, Dominika, Menkyova, Ingrid, Drahota, Jiri, Mazouchova, Aneta, Adamkova, Jana, Ampapa, Radek, Grunermelova, Marketa, Peterka, Marek, Recmanova, Eva, Rockova, Petra, Rous, Matous, Stetkarova, Ivana, Valis, Martin, Vachova, Marta, Woznicova, Ivana, Horakova, Dana

Get full text

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech an... by Hrnciarova, Tereza, Drahota, Jiri, Spelman, Tim, Hillert, Jan, Lycke, Jan, Kubala Havrdova, Eva, Recmanova, Eva, Adamkova, Jana, Mares, Jan, Libertinova, Jana, Pavelek, Zbysek, Hradilek, Pavel, Ampapa, Radek, Stetkarova, Ivana, Peterka, Marek, Martinkova, Alena, Stourac, Pavel, Grunermelova, Marketa, Vachova, Marta, Dufek, Michal, Horakova, Dana

Get full text